Contravisory Investment Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,207
Closed -$794K 424
2025
Q3
$794K Buy
3,207
+1,133
+55% +$271K 0.15% 96
2025
Q2
$498K Buy
+2,074
New +$483K 0.1% 149
2022
Q4
Sell
-2,398
Closed -$399K 335
2022
Q3
$399K Sell
2,398
-60
-2% -$12.2K 0.13% 93
2022
Q2
$507K Sell
2,458
-66
-3% -$14.9K 0.16% 69
2022
Q1
$610K Sell
2,524
-305
-11% -$70.7K 0.17% 67
2021
Q4
$689K Buy
2,829
+325
+13% +$74.3K 0.19% 71
2021
Q3
$512K Buy
2,504
+182
+8% +$38.9K 0.16% 76
2021
Q2
$479K Buy
2,322
+12
+0.5% +$2.42K 0.14% 85
2021
Q1
$440K Buy
2,310
+40
+2% +$7.42K 0.14% 83
2020
Q4
$430K Sell
2,270
-116
-5% -$21.6K 0.13% 77
2020
Q3
$420K Hold
2,386
0.14% 74
2020
Q2
$370K Buy
2,386
+2,172
+1,015% +$331K 0.14% 78
2020
Q1
$30K Buy
+214
New +$32K 0.01% 228

Other funds holding STE

Contravisory Investment Management's STE Position: Q4 2025 in Review

Contravisory Investment Management sold out of Steris (STE) in Q4 2025, closing a stake of 3,207 shares — an estimated $794K sold.

Contravisory Investment Management first reported a position in STE in Q1 2020 and held it in 13 quarters. The position peaked at $794K in Q3 2025. 897 funds tracked by Wall St. Rank hold STE as of Q4 2025.

  • Contravisory Investment Management reported no remaining Steris position as of Q4 2025 after selling out during the quarter.
  • Contravisory Investment Management sold 3,207 Steris shares in Q4 2025, an estimated $794K.
  • Contravisory Investment Management first reported a position in Steris in Q1 2020 and held it in 13 quarters.
  • Contravisory Investment Management's Steris position peaked at $794K in Q3 2025.
  • 897 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on Contravisory Investment Management's 13F filing for Q4 2025, filed 12 Jan 2026.